Prevalence and factors associated with hypertension among adults with and without HIV in Western Kenya.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 29 03 2021
accepted: 22 12 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 22 2 2022
Statut: epublish

Résumé

The burden of cardiovascular disease (CVD) is increasing in sub-Saharan Africa with untreated hypertension being a major contributing factor. Understanding the magnitude of the problem and risk factors associated with HIV and long-term antiretroviral therapy (ART) is critically important for designing effective programs for diagnosing and treating hypertension in Kenya. In this cross-sectional study, we enrolled 300 persons with HIV (PWH) on long term ART (≥6 months) and 298 HIV-negative adults seeking care at the Kisumu County Hospital between September 2017 and May 2018. Hypertension was defined as blood pressure of ≥140/90mmHg or a previous hypertension diagnosis. Multivariate regression was used to assess the association between hypertension and HIV adjusting for age, sex, and known CVD risk factors. Overall prevalence of hypertension was 22%. PWH had a lower prevalence of hypertension than HIV-negative persons (16% vs 27% respectively; p<0.002). In multivariate analyses, persons with HIV were 37% less likely to have hypertension compared to HIV-negative individuals (adjusted prevalence ratio 0.63; 95% confidence interval: 0.46-0.86). Other factors that were associated with hypertension in all participants included older age >40 years, body mass index (BMI) >25 kg/m2 and low-density lipoproteins ≥130mg/dL. Among PWH, being older than 40 years and higher BMI >30 kg/m2 were associated with hypertension. Prevalence of hypertension was high, affecting nearly one in every 4 adults, and associated with older age, higher BMI and high low-density lipoproteins. PWH on long-term ART had significantly lower prevalence of hypertension compared to HIV-negative individuals, potentially due to increased access to healthcare services and interaction with prevention messaging. Interventions to increase screening for and prevention of hypertension in the community for all adults are warranted.

Identifiants

pubmed: 35007291
doi: 10.1371/journal.pone.0262400
pii: PONE-D-21-10329
pmc: PMC8746744
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0262400

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009580
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH115789
Pays : United States
Organisme : FIC NIH HHS
ID : R21 TW010459
Pays : United States

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest or competing financial interests.

Références

Medicine (Baltimore). 2020 Jul 2;99(27):e20845
pubmed: 32629671
Ann Med Health Sci Res. 2015 Jan-Feb;5(1):71-7
pubmed: 25745581
PLoS One. 2016 May 27;11(5):e0156309
pubmed: 27232186
BMC Public Health. 2017 Jul 10;18(1):2
pubmed: 28693458
Kidney Int Rep. 2018 Apr 22;3(4):905-915
pubmed: 29989050
AIDS Care. 2018 May;30(5):544-550
pubmed: 28990417
PLoS One. 2012;7(3):e32638
pubmed: 22427857
J Gastrointest Surg. 2009 May;13(5):890-5
pubmed: 19132450
J Hum Hypertens. 2016 Jun;30(6):355-62
pubmed: 26446389
Pan Afr Med J. 2021 Feb 25;38:216
pubmed: 34046122
BMC Public Health. 2015 Dec 05;15:1211
pubmed: 26637309
J Infect Dis. 2009 Oct 15;200(8):1212-5
pubmed: 19728788
BMC Public Health. 2014 Nov 18;14:1177
pubmed: 25407513
BMC Med. 2014 Jul 29;12:125
pubmed: 25070128
JAMA. 2018 Nov 6;320(17):1749-1750
pubmed: 30398611
Curr Hypertens Rep. 2019 Jun 4;21(7):56
pubmed: 31165257
Eur J Clin Nutr. 2010 Jan;64(1):2-5
pubmed: 19935820
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
Glob Health Action. 2017;10(1):1321279
pubmed: 28598724
Blood Press Monit. 2013 Oct;18(5):247-51
pubmed: 23873153
Trans R Soc Trop Med Hyg. 2006 Mar;100(3):191-9
pubmed: 16274715
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Int J Hypertens. 2016;2016:1656938
pubmed: 27293880
PLoS One. 2011;6(7):e22288
pubmed: 21779407
Am J Hypertens. 2018 Mar 10;31(4):387-388
pubmed: 29136102
BMC Public Health. 2015 Dec 17;15:1251
pubmed: 26679701
SAGE Open Med. 2018 Feb 12;6:2050312118756663
pubmed: 29468066

Auteurs

Jerusha Nyabiage Mogaka (JN)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.

Monisha Sharma (M)

Department of Global Health, University of Washington, Seattle, WA, United States of America.

Tecla Temu (T)

Department of Global Health, University of Washington, Seattle, WA, United States of America.

Sarah Masyuko (S)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Ministry of Health, Nairobi, Kenya.

John Kinuthia (J)

Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.

Alfred Osoti (A)

Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Department of Clinical Medicine and Therapeutics, College of Health Sciences, University of Nairobi, Nairobi, Kenya.

Jerry Zifodya (J)

Department of Medicine, Section of Pulmonary, Critical Care, & Environmental Medicine, Tulane University, New Orleans, LA, United States of America.

Damalie Nakanjako (D)

Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Anne Njoroge (A)

Department of Global Health, University of Washington, Seattle, WA, United States of America.

Amos Otedo (A)

Ministry of Health, Nairobi, Kenya.

Stephanie Page (S)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Medicine, University of Washington, Seattle, WA, United States of America.

Carey Farquhar (C)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Medicine, University of Washington, Seattle, WA, United States of America.
Department of Epidemiology, University of Washington, Seattle, WA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH